Literature DB >> 6607758

Pre-B cell leukemia associated with chromosome translocation 1;19.

A J Carroll, W M Crist, R T Parmley, M Roper, M D Cooper, W H Finley.   

Abstract

Chromosome banding studies on 60 children with acute lymphocytic leukemia (ALL), including "null," pre-B, B, and T cell phenotypes, were performed. In 4 of 17 patients with pre-B cell ALL, we noted a previously undescribed chromosome translocation, t(1;19)(q23;q13). This translocation was not found in patients with "null" cell, B cell, or T cell ALL. Since each patient with the 1;19 translocation experienced early treatment failure, t(1;19)(q23;q13) may mark a subgroup of patients with pre-B cell ALL who have an especially poor prognosis.

Entities:  

Mesh:

Year:  1984        PMID: 6607758

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  27 in total

1.  Critical role for a single leucine residue in leukemia induction by E2A-PBX1.

Authors:  Richard Bayly; Takayuki Murase; Brandy D Hyndman; Rachel Savage; Salima Nurmohamed; Kim Munro; Richard Casselman; Steven P Smith; David P LeBrun
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

Review 2.  Biology and treatment of adult acute lymphoblastic leukemia.

Authors:  L Levitt; R Lin
Journal:  West J Med       Date:  1996-02

3.  The oncoprotein E2A-Pbx1a collaborates with Hoxa9 to acutely transform primary bone marrow cells.

Authors:  U Thorsteinsdottir; J Krosl; E Kroon; A Haman; T Hoang; G Sauvageau
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 4.  Transcription factor networks in B-cell differentiation link development to acute lymphoid leukemia.

Authors:  Rajesh Somasundaram; Mahadesh A J Prasad; Jonas Ungerbäck; Mikael Sigvardsson
Journal:  Blood       Date:  2015-05-19       Impact factor: 22.113

Review 5.  Chromosome abnormalities in acute leukemia: its clinical implications and age of onset.

Authors:  R Abe; Y Shiga; T Uchida; S Kariyone
Journal:  Indian J Pediatr       Date:  1989 Nov-Dec       Impact factor: 1.967

6.  Adults with acute lymphoblastic leukemia and translocation (1;19) abnormality have a favorable outcome with hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with methotrexate and high-dose cytarabine chemotherapy.

Authors:  Ravin Garg; Hagop Kantarjian; Deborah Thomas; Stefan Faderl; Farhad Ravandi; Denise Lovshe; Sherry Pierce; Susan O'Brien
Journal:  Cancer       Date:  2009-05-15       Impact factor: 6.860

7.  High molecular weight DNA from fixed cytogenetic preparations.

Authors:  P E Barker; J R Testa; N Z Parsa; R Snyder
Journal:  Am J Hum Genet       Date:  1986-11       Impact factor: 11.025

8.  Increased risk for CNS relapse in pre-B cell leukemia with the t(1;19)/TCF3-PBX1.

Authors:  S Jeha; D Pei; S C Raimondi; M Onciu; D Campana; C Cheng; J T Sandlund; R C Ribeiro; J E Rubnitz; S C Howard; J R Downing; W E Evans; M V Relling; C-H Pui
Journal:  Leukemia       Date:  2009-03-12       Impact factor: 11.528

9.  E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice.

Authors:  M P Kamps; D Baltimore
Journal:  Mol Cell Biol       Date:  1993-01       Impact factor: 4.272

10.  Clinical features and prognostic implications of TCF3-PBX1 and ETV6-RUNX1 in adult acute lymphoblastic leukemia.

Authors:  Thomas Burmeister; Nicola Gökbuget; Stefan Schwartz; Lars Fischer; Daniela Hubert; Annette Sindram; Dieter Hoelzer; Eckhard Thiel
Journal:  Haematologica       Date:  2009-08-27       Impact factor: 9.941

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.